To our knowledge, this is the first report demonstrating oncogene-driven epigenetic silencing of chemokine genes, which might lead to the immune evasion of cancer, as well as the resistance to ICI, which may open a new possibility to overcome the ICI resistance of EGFR-mt LA. The gene discussed is EGFR; the disease is cancer.